Kartos Therapeutics

Kartos Therapeutics

Biotechnology, 275 Shoreline Dr, Redwood City, California, 94065, United States, 11-50 Employees

kartosthera.com

  • LinkedIn

phone no Phone Number: +16*********

Who is KARTOS THERAPEUTICS

Kartos Therapeutics is a privately held, clinical-stage biopharmaceutical company developing a potentially best-in-class MDM2 inhibitor. Launched in 2018 by proven industry veterans, we a...

Read More

map
  • 275 Shoreline Dr, Redwood City, California, 94065, United States Headquarters: 275 Shoreline Dr, Redwood City, California, 94065, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from KARTOS THERAPEUTICS

Kartos Therapeutics Org Chart and Mapping

Employees

May Gallardo

Senior Director Finance

Anna Nekhymchuk

Senior Clinical Trial Manager

Chunyan Gu

Director, Translational Science

Jordan Blevins

Senior Clinical Trial Manager

Sheryl Zausen

Sr. Director, Clinical Data Management

Anna Harris

Senior Clinical Trial Manager

Amanda Cannon

Senior Director Regulatory Affairs

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Kartos Therapeutics

Answer: Kartos Therapeutics's headquarters are located at 275 Shoreline Dr, Redwood City, California, 94065, United States

Answer: Kartos Therapeutics's phone number is +16*********

Answer: Kartos Therapeutics's official website is https://kartosthera.com

Answer: Kartos Therapeutics's revenue is $25 Million to $50 Million

Answer: Kartos Therapeutics's SIC: 8731

Answer: Kartos Therapeutics has 11-50 employees

Answer: Kartos Therapeutics is in Biotechnology

Answer: Kartos Therapeutics contact info: Phone number: +16********* Website: https://kartosthera.com

Answer: Kartos Therapeutics is a privately held, clinical-stage biopharmaceutical company developing a potentially best-in-class MDM2 inhibitor. Launched in 2018 by proven industry veterans, we are a passionate team based in Redwood City, California, and Bellevue, Washington. We have brought together scientists and clinicians with a deep understanding of hematology and oncology and an experienced leadership team. Together, were building an exciting biotechnology company with a culture defined by caring, ambition, dedication, and teamwork!

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access